182 related articles for article (PubMed ID: 4880674)
1. A double blind study of 1-dopa treatment in Parkinson's disease.
Rinne UK; Sonninen V
Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674
[No Abstract] [Full Text] [Related]
2. [L-Dopa therapy in Parkinson's disease. A double-blind study].
Worm-Petersen J; Dupont E; Mikkelsen B
Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
[No Abstract] [Full Text] [Related]
3. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Rosati G; Agnetti V; Mura F; Granieri E
Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
[No Abstract] [Full Text] [Related]
4. A year's experience of L-DOPA in the treatment of Parkinson's disease.
Guidetti B; Giuffrè R
Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
[No Abstract] [Full Text] [Related]
5. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
6. DOPA in Parkinson's disease.
Lancet; 1969 Apr; 1(7600):871-2. PubMed ID: 4180531
[No Abstract] [Full Text] [Related]
7. [Treatment with L-dopa in Parkinsonian syndromes].
De Renzi E; Pieczuro A
Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
[No Abstract] [Full Text] [Related]
8. The clinical use of levodopa in the treatment of Parkinson's disease.
McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
[No Abstract] [Full Text] [Related]
9. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
10. Treatment of parkinsonism with levodopa.
Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
[No Abstract] [Full Text] [Related]
11. [Results of treatment of Parkinsonism with L-dopa].
De Divitiis E; D'Andrea F; Signorelli CD
Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
[No Abstract] [Full Text] [Related]
12. [The treatment of Parkinson's syndrome with L-dopa].
Völler GW; Kerstan J
Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
[No Abstract] [Full Text] [Related]
13. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
Antonini F; Baroni A; Roveyaz L
Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
[No Abstract] [Full Text] [Related]
14. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
15. Quantitative measurements of L-dopa therapy in Parkinson's disease.
Webster DD
Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
[No Abstract] [Full Text] [Related]
16. Effects of L-dopa in Parkinson's disease.
Godwin-Austen RB; Tomlinson EB; Frears CC; Kok HW
Lancet; 1969 Jul; 2(7613):165-8. PubMed ID: 4183130
[No Abstract] [Full Text] [Related]
17. [Current treatment of Parkinson syndrome with L-dopa].
Gerstendbrand F; Gründig E; Musiol A
Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
[No Abstract] [Full Text] [Related]
18. Treatment of Parkinson's disease with L-dopa: a current appraisal.
Kofman O
Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of parkinsonism with the drug L-DOPA].
Stoliarova LG; Kistenev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
[No Abstract] [Full Text] [Related]
20. A quantitative evaluation of the effects of L-dopa on Parkinson's disease.
Velasco F; Velasco M
Neuropharmacology; 1973 Feb; 12(2):89-99. PubMed ID: 4595553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
